Hansoh Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Hansoh Pharmaceutical Group has a total shareholder equity of CN¥25.8B and total debt of CN¥4.2B, which brings its debt-to-equity ratio to 16.4%. Its total assets and total liabilities are CN¥33.0B and CN¥7.2B respectively. Hansoh Pharmaceutical Group's EBIT is CN¥2.7B making its interest coverage ratio -2.8. It has cash and short-term investments of CN¥24.9B.
Key information
16.4%
Debt to equity ratio
CN¥4.22b
Debt
| Interest coverage ratio | -2.8x |
| Cash | CN¥24.88b |
| Equity | CN¥25.79b |
| Total liabilities | CN¥7.24b |
| Total assets | CN¥33.04b |
Recent financial health updates
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22Recent updates
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price
Nov 07Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Oct 11A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 14The Hansoh Pharmaceutical Group (HKG:3692) Share Price Is Up 51% And Shareholders Are Holding On
Jan 31Will Weakness in Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Stock Prove Temporary Given Strong Fundamentals?
Dec 08
Financial Position Analysis
Short Term Liabilities: 3692's short term assets (CN¥28.9B) exceed its short term liabilities (CN¥6.9B).
Long Term Liabilities: 3692's short term assets (CN¥28.9B) exceed its long term liabilities (CN¥381.5M).
Debt to Equity History and Analysis
Debt Level: 3692 has more cash than its total debt.
Reducing Debt: 3692's debt to equity ratio has increased from 0% to 16.4% over the past 5 years.
Debt Coverage: 3692's debt is well covered by operating cash flow (73.8%).
Interest Coverage: 3692 earns more interest than it pays, so coverage of interest payments is not a concern.